Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Soo-Jeong | - |
dc.contributor.author | Cheong, June-Won | - |
dc.contributor.author | Kim, Dae-Young | - |
dc.contributor.author | Lee, Je-Hwan | - |
dc.contributor.author | Lee, Kyoo-Hyung | - |
dc.contributor.author | Kim, Yeo-Kyeoung | - |
dc.contributor.author | Kim, Hyeong-Joon | - |
dc.contributor.author | Song, Ik-Chan | - |
dc.contributor.author | Jo, Deog-Yeon | - |
dc.contributor.author | Lee, Jeong-Ok | - |
dc.contributor.author | Bang, Soo-Mee | - |
dc.contributor.author | Park, Jinny | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Lee, Won-Sik | - |
dc.contributor.author | Joo, Young-Don | - |
dc.contributor.author | Maeng, Chi Hoon | - |
dc.contributor.author | Yoon, Hwi-Joong | - |
dc.contributor.author | Lee, Na-Ri | - |
dc.contributor.author | Kwak, Jae-Yong | - |
dc.contributor.author | Kim, Kyoung Ha | - |
dc.contributor.author | Won, Jong-Ho | - |
dc.contributor.author | Han, Bo Ram | - |
dc.contributor.author | Zang, Dae Young | - |
dc.contributor.author | Moon, Joon Ho | - |
dc.contributor.author | Sohn, Sang Kyun | - |
dc.contributor.author | Bae, Sung Hwa | - |
dc.contributor.author | Ryoo, Hun Mo | - |
dc.contributor.author | Kim, Sung-Yong | - |
dc.contributor.author | Lee, Mark Hong | - |
dc.contributor.author | Min, Yoo Hong | - |
dc.date.available | 2020-02-28T16:45:30Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-08 | - |
dc.identifier.issn | 0925-5710 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12412 | - |
dc.description.abstract | The present study sought to elucidate the role of induction and consolidation therapy in elderly patients. We retrospectively collected data of 477 patients who were aged over 60 years at the time of acute myeloid leukemia (AML) diagnosis. The median overall survival (OS) was 339 days in the induction group (n = 266) and 86 days in the best supportive care group (n = 211) (P < 0.001). In the induction group, the complete remission (CR) rate was 58.3 %, and treatment-related death was 15.4 %. Successful induction was related to good performance [Eastern Cooperative Oncology Group (ECOG < 2)] [hazard ratio (HR) 3.215; P = 0.002]. Mortality correlated with failure to achieve CR (HR 4.059; P < 0.001) and poor performance status (ECOG > 2) (HR 2.731; P = 0.035). In CR patients, poor karyotype and absence of consolidation (HR 2.313; P = 0.003) correlated with mortality. More than one cycle of consolidation was associated with better OS (P < 0.001). Lack of salvage therapy was associated with mortality in patients who did not achieve CR (HR 3.223; P = 0.005). Intensive induction in patients with good performance and > 1 cycle of consolidation after CR may be the best strategy for improving OS in elderly AML patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER JAPAN KK | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF HEMATOLOGY | - |
dc.subject | ACUTE MYELOGENOUS LEUKEMIA | - |
dc.subject | COLONY-STIMULATING FACTOR | - |
dc.subject | COUNCIL AML11 TRIAL | - |
dc.subject | OLDER PATIENTS | - |
dc.subject | INTENSIVE CHEMOTHERAPY | - |
dc.subject | TREATMENT OUTCOMES | - |
dc.subject | ONCOLOGY-GROUP | - |
dc.subject | SURVIVAL | - |
dc.subject | AGE | - |
dc.subject | CLASSIFICATION | - |
dc.title | Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000340523700007 | - |
dc.identifier.doi | 10.1007/s12185-014-1617-8 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF HEMATOLOGY, v.100, no.2, pp.141 - 151 | - |
dc.identifier.scopusid | 2-s2.0-84906101413 | - |
dc.citation.endPage | 151 | - |
dc.citation.startPage | 141 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF HEMATOLOGY | - |
dc.citation.volume | 100 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Park, Jinny | - |
dc.contributor.affiliatedAuthor | Lee, Jae Hoon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Elderly AML | - |
dc.subject.keywordAuthor | Induction | - |
dc.subject.keywordAuthor | Consolidation | - |
dc.subject.keywordPlus | ACUTE MYELOGENOUS LEUKEMIA | - |
dc.subject.keywordPlus | COLONY-STIMULATING FACTOR | - |
dc.subject.keywordPlus | COUNCIL AML11 TRIAL | - |
dc.subject.keywordPlus | OLDER PATIENTS | - |
dc.subject.keywordPlus | INTENSIVE CHEMOTHERAPY | - |
dc.subject.keywordPlus | TREATMENT OUTCOMES | - |
dc.subject.keywordPlus | ONCOLOGY-GROUP | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | AGE | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.